Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
Xingyong Chen(Fujian Medical University), Yinzhou Wang(Fujian Medical University)
Cited by 59
Related Papers
LMP2 deficiency causes abnormal metabolism, oxidative stress, neuroinflammation, myelin loss and neurobehavioral dysfunctions
|Journal of Translational Medicine|2023|12
Inhibition of the Immunoproteasome Subunit LMP7 Ameliorates Cerebral White Matter Demyelination Possibly via TGFβ/Smad Signaling
|Evidence-based Complementary and Alternative Medicine|2021|10